Zurcher Kantonalbank Zurich Cantonalbank Acquires 6,105 Shares of The Clorox Company (NYSE:CLX)

Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in The Clorox Company (NYSE:CLX) by 4.1% in the 1st quarter, HoldingsChannel.com reports. The fund owned 155,767 shares of the company’s stock after buying an additional 6,105 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Clorox were worth $22,937,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. OneDigital Investment Advisors LLC bought a new position in shares of Clorox in the 1st quarter worth about $247,000. Brown Miller Wealth Management LLC bought a new position in shares of Clorox in the 1st quarter worth about $399,000. Roman Butler Fullerton & Co. acquired a new stake in shares of Clorox in the 1st quarter valued at about $400,000. Wedge Capital Management L L P NC grew its stake in shares of Clorox by 33.5% in the 1st quarter. Wedge Capital Management L L P NC now owns 28,510 shares of the company’s stock valued at $4,198,000 after buying an additional 7,159 shares during the period. Finally, Cornerstone Wealth Group LLC grew its stake in shares of Clorox by 19.0% in the 1st quarter. Cornerstone Wealth Group LLC now owns 25,582 shares of the company’s stock valued at $3,767,000 after buying an additional 4,085 shares during the period. 78.53% of the stock is owned by institutional investors.

Insider Buying and Selling at Clorox

In other Clorox news, Director Pierre R. Breber bought 4,000 shares of the business’s stock in a transaction dated Wednesday, May 7th. The shares were purchased at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the purchase, the director directly owned 4,000 shares of the company’s stock, valued at approximately $546,280. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.57% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

CLX has been the subject of several research reports. Barclays reduced their target price on Clorox from $129.00 to $119.00 and set an “underweight” rating for the company in a research note on Tuesday, July 15th. Evercore ISI set a $140.00 target price on Clorox and gave the company an “underperform” rating in a research note on Tuesday, May 6th. Wells Fargo & Company reduced their target price on Clorox from $142.00 to $135.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 9th. Citigroup restated a “neutral” rating and issued a $135.00 target price (down from $140.00) on shares of Clorox in a research note on Tuesday, July 15th. Finally, Morgan Stanley reduced their target price on Clorox from $165.00 to $150.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 6th. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $144.83.

Clorox Stock Performance

Shares of CLX opened at $127.29 on Tuesday. The company has a debt-to-equity ratio of 13.07, a quick ratio of 0.44 and a current ratio of 0.74. The stock has a 50 day moving average price of $126.62 and a two-hundred day moving average price of $139.79. The firm has a market capitalization of $15.69 billion, a P/E ratio of 22.85, a P/E/G ratio of 3.44 and a beta of 0.51. The Clorox Company has a 52 week low of $117.35 and a 52 week high of $171.37.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12). The company had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.74 billion. Clorox had a return on equity of 324.23% and a net margin of 9.89%. The business’s revenue for the quarter was down 8.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.71 earnings per share. Equities analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.